Breaking News Instant updates and real-time market news.

COST

Costco

$245.22

-1 (-0.41%)

, DG

Dollar General

$123.75

-0.13 (-0.10%)

07:19
04/17/19
04/17
07:19
04/17/19
07:19

Costco price target raised to $270 from $245 at Oppenheimer

Oppenheimer analyst Rupesh Parikh raised his price target for Costco (COST) to $270 from $245 after spending time visiting senior management. The analyst overall walked away still constructive on Costco's prospects, and continues to believe the company remains best positioned in his entire food and grocery coverage to deliver sustainable top- and bottom-line performance. Parikh still sees the potential for a special dividend of as much as $9-plus in coming quarters. The analyst notes that Costco and Dollar General (DG) remain his top food retailing/discounter picks. He reiterates an Outperform rating on Costco's shares.

COST

Costco

$245.22

-1 (-0.41%)

DG

Dollar General

$123.75

-0.13 (-0.10%)

  • 08

    May

  • 30

    May

COST Costco
$245.22

-1 (-0.41%)

04/01/19
LOOP
04/01/19
NO CHANGE
Target $265
LOOP
Buy
Costco price target raised to $265 from $260 at Loop Capital
Loop Capital analyst Laura Champine raised her price target on Costco to $265 from $260 and reiterated a Buy rating following mid-quarter estimate adjustments. In a research note to investors, Champine says the most meaningful change made to her model is a slight increase to gross margin in fiscal 2020 and beyond as she expects increased penetration of private label product to continue to boost product margin. She also expects an acceleration from 5% same-store sales growth in the February quarter to 7% in the May quarter as weather improves.
04/01/19
SBSH
04/01/19
UPGRADE
Target $18
SBSH
Neutral
Bed Bath & Beyond upgraded to Neutral from Sell at Citi
Citi analyst Geoff Small upgraded Bed Bath & Beyond (BBBY) to Neutral from Sell and raised his price target for the shares to $18 from $10 after taking over coverage of the name. Citi transferred coverage of Broadlines & Hardlines Retail names to Small. The analyst assumed coverage with Buy ratings on AutoZone (AZO), BJ's Wholesale (BJ), Home Depot (HD), Lowe's (LOW), O'Reilly Automotive (ORLY) and Walmart (WMT). The U.S. consumer remains on "solid footing" amid low unemployment, rising wages, declining gas prices, manageable levels of debt, and elevated consumer confidence, Small tells investors in a research note. However, he points out that we are in the ninth year of the current economic expansion and "the possibility of a macroeconomic slowdown cannot be ignored." The analyst prefers retailers operating in "defensive sectors that are less susceptible to disruption by online competitors," namely auto parts, broadlines and home improvement retail. Small also assumed Advance Auto Parts (AAP), Best Buy (BBY), Costco (COST) and Office Depot (ODP) with Neutral ratings.
04/04/19
BARD
04/04/19
NO CHANGE
Target $250
BARD
Outperform
Costco March comps to rebound, says Baird
Baird analyst Peter Benedict kept his Outperform rating and $250 price target on Costco ahead of its March comps results next week, saying he expects the month to rebound from a softer figure of 4.6% in February as the headwinds of weather and Easter calendar shift fade. The analyst estimates March comps to rise 7%-8% and believes that the company's "entrenched value position, loyal membership base, and emerging omni-channel sophistication" should sustain its standout position in retail.
04/11/19
STFL
04/11/19
NO CHANGE
Target $261
STFL
Buy
Costco price target raised to $261 from $247 at Stifel
Stifel analyst Mark Astrachan said Costco's total and U.S. core comparable sales growth weakness in March "is a watchpoint," but he is more inclined to buy on weakness given that its comp growth still remains "distantly best-in-class." The analyst, who sees the consensus Q3 comp growth forecast of 4.6% for Costco as achievable, keeps a Buy rating on shares and raised his price target to $261 from $247.
DG Dollar General
$123.75

-0.13 (-0.10%)

03/18/19
LEHM
03/18/19
UPGRADE
Target $125
LEHM
Overweight
Barclays upgrades Dollar General to Overweight on post-earnings selloff
Barclays analyst Karen Short upgraded Dollar General to Overweight from Equal Weight and raised her price target for the shares to $125 from $102. The company is doing what all "best-in-class" retailers do, it is investing from a position of strength to enhance its competitive edge, even if it means near-term guidance disappoints, Short tells investors in a research note. As such, the analyst believes last week's post-earnings selloff in shares of Dollar General has created an attractive entry point. The company offers long-term growth and "rare defensive characteristics," says Short.
03/18/19
03/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Okta (OKTA) upgraded to Buy from Neutral at Goldman Sachs with analyst Heather Bellini saying the company's "strong" results since its April 2017 initial public offering continue to demonstrate the growing role that identity is playing in the wider enterprise information technology ecosystem. 2. Dollar General (DG) upgraded to Overweight from Equal Weight at Barclays with analyst Karen Short saying the company is doing what all "best-in-class" retailers do, it is investing from a position of strength to enhance its competitive edge, even if it means near-term guidance disappoints. 3. Johnson Controls (JCI) upgraded to Outperform from Market Perform at Wells Fargo with the firm's analyst saying the timing is now better for the story to play out. 4. Drive Shack (DS) upgraded to Outperform from In-Line at Imperial Capital with analyst George Kelly saying he is optimistic that the company's new venues opening this summer and fall will perform better than Orlando, and longer-term, he believe Drive Shack's management will be able to "navigate the rapidly growing golf entertainment space." 5. Dentsply Sirona (XRAY) upgraded to Outperform from Market Perform at William Blair with analyst John Kreger citing what he viewed as a positive International Dental Show. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
EVER
03/20/19
INITIATION
Target $100
EVER
Underperform
Dollar General initiated with an Underperform at Evercore ISI
Evercore ISI analyst Michael Montani started Dollar General with an Underperform rating and $100 base case price target, citing his view that a moderation in traffic and cost inflation are likely to pressure its margins over the long-term.
04/05/19
JPMS
04/05/19
NO CHANGE
Target $133
JPMS
Overweight
Dollar General price target raised to $133 from $121 at JPMorgan
JPMorgan analyst Matthew Boss raised his price target for Dollar General to $133 from $121 after hosting investor meetings with management. The analyst sees the company transitioning into "growth mode" and keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

EQBK

Equity Bancshares

$29.45

-0.3 (-1.01%)

16:58
04/22/19
04/22
16:58
04/22/19
16:58
Hot Stocks
Equity Bancshares announces up to 1.1M share repurchase plan »

The board of Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

EQBK

Equity Bancshares

$29.45

-0.3 (-1.01%)

16:55
04/22/19
04/22
16:55
04/22/19
16:55
Earnings
Equity Bancshares reports Q1 adj. EPS 61c, consensus 65c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

EMES

Emerge Energy

$1.68

0.16 (10.53%)

16:53
04/22/19
04/22
16:53
04/22/19
16:53
Hot Stocks
Emerge Energy enters into a restructuring support agreement with its subsidiary »

Emerge Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMC

Omnicom

$81.83

-0.47 (-0.57%)

16:51
04/22/19
04/22
16:51
04/22/19
16:51
Hot Stocks
Omnicom officer Jonathan Nelson sells over $400K in company shares »

Omnicom officer Jonathan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

CE

Celanese

$104.50

-0.7 (-0.67%)

16:50
04/22/19
04/22
16:50
04/22/19
16:50
Hot Stocks
Celanese reports Q1 EBIT $421M vs. $474M last year »

Reports Q1 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CE

Celanese

$104.50

-0.7 (-0.67%)

16:49
04/22/19
04/22
16:49
04/22/19
16:49
Hot Stocks
Celanese CEO sees Q2 conditions similar to Q1 »

CEO Mark Rohr says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CE

Celanese

$104.50

-0.7 (-0.67%)

16:48
04/22/19
04/22
16:48
04/22/19
16:48
Earnings
Celanese backs FY19 EPS view of about $10.50, consensus $10.37 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CE

Celanese

$104.50

-0.7 (-0.67%)

16:46
04/22/19
04/22
16:46
04/22/19
16:46
Earnings
Celanese reports Q1 adjusted EPS $2.62, consensus $2.41 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SIMO

Silicon Motion

$42.15

-0.52 (-1.22%)

16:44
04/22/19
04/22
16:44
04/22/19
16:44
Downgrade
Silicon Motion rating change  »

Silicon Motion cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 28

    May

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:42
04/22/19
04/22
16:42
04/22/19
16:42
Hot Stocks
Tesla CEO sees Robotaxis on the road in 2020 »

Says cost of Robotaxi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

16:39
04/22/19
04/22
16:39
04/22/19
16:39
Conference/Events
SunTrust gov't affairs analysts to hold an analyst/industry conference call »

Analysts hold an…

BA

Boeing

$375.02

-5 (-1.32%)

, TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
On The Fly
Fly Intel: Wall Street's top stories for Monday »

The major averages were…

BA

Boeing

$375.02

-5 (-1.32%)

TSLA

Tesla

$262.90

-10.35 (-3.79%)

KMB

Kimberly-Clark

$130.24

6.76 (5.47%)

GWW

Grainger

$291.05

-17.215 (-5.58%)

SSNLF

Samsung

$0.00

(0.00%)

KEYW

KEYW

$11.16

3.31 (42.17%)

JEC

Jacobs Engineering

$78.69

1.755 (2.28%)

AKRX

Akorn

$2.98

0.21 (7.58%)

EAF

GrafTech

$12.35

-1.58 (-11.34%)

ISRG

Intuitive Surgical

$490.70

-37.34 (-7.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 01

    May

  • 01

    May

  • 01

    May

  • 02

    May

  • 03

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 09

    May

  • 20

    May

  • 29

    May

  • 05

    Jun

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
Hot Stocks
Tesla CEO sees Model S/3/X production of 10,000/wk in 2019 »

Sees reaching Model S,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

LENS

Presbia

$0.56

-0.0034 (-0.61%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
Hot Stocks
Breaking Hot Stocks news story on Presbia »

Presbia trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$12.77

0.1 (0.79%)

16:36
04/22/19
04/22
16:36
04/22/19
16:36
Hot Stocks
Alder Biopharmaceuticals: FDA accepts for review the BLA for eptinezumab »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

GPC

Genuine Parts

$103.62

-1.84 (-1.74%)

16:33
04/22/19
04/22
16:33
04/22/19
16:33
Hot Stocks
Genuine Parts CEO Paul Donahue to also serve as board chairman »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:32
04/22/19
04/22
16:32
04/22/19
16:32
Hot Stocks
Tesla says Autopilot observes driver, pedestrian tendencies »

Says Autopilot uses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

HSTM

HealthStream

$27.23

0.11 (0.41%)

16:32
04/22/19
04/22
16:32
04/22/19
16:32
Earnings
HealthStream backs FY19 revenue view $251M-$258M, consensus $255.84M »

Raises FY19 CapEx view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 28

    May

HSTM

HealthStream

$27.23

0.11 (0.41%)

16:31
04/22/19
04/22
16:31
04/22/19
16:31
Earnings
HealthStream reports Q1 EPS 15c, consensus 7c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 28

    May

RCKT

Rocket Pharmaceuticals

$17.78

0.91 (5.39%)

16:31
04/22/19
04/22
16:31
04/22/19
16:31
Initiation
Rocket Pharmaceuticals initiated  »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$16.66

-0.41 (-2.40%)

16:30
04/22/19
04/22
16:30
04/22/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Guess »

Guess down 3.9% at $16…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
04/22/19
04/22
16:30
04/22/19
16:30
Options
Preliminary option volume of 15.3M today »

Preliminary option volume…

GRTS

Gritstone Oncology

$14.57

0.86 (6.27%)

16:29
04/22/19
04/22
16:29
04/22/19
16:29
Syndicate
Gritstone Oncology files to sell 6.5M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

$46.47

-0.87 (-1.84%)

16:28
04/22/19
04/22
16:28
04/22/19
16:28
Earnings
American Campus reports Q1 FFO 69c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 01

    May

GES

Guess

$16.66

-0.41 (-2.40%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Hot Stocks
Guess to initiate $150M stock buyback »

Guess intends to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.